Anzeige

Archive

Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)

DOI: https://doi.org/10.1160/TH07-10-0623
Issue: 2008: 99/3 (Mar) pp. 457-645
Pages: 576-585

Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins

Mathieu Provençal 1, Marisol Michaud 1, Édith Beaulieu 1, David Ratel 1, Georges-Étienne Rivard 2, Denis Gingras 1, Richard Béliveau1,2
1 Laboratoire de médecine moléculaire, Hôpital Ste-Justine-UQAM, Centre de cancérologie Charles-Bruneau, Centre de Recherche de l’Hôpital Sainte-Justine, Chemin Côte-Sainte-Catherine, Montréal, Québec, Canada; 2 Service d'Hématologie-Oncologie, Hôpital Ste-Justine, Montréal, Québec, Canada

Keywords

angiogenesis, TFPI, endothelial cell migration, focal adhesion complexes, extracellular signal-regulated kinases

Summary

Tissue factor pathway inhibitor (TFPI) is a plasma Kunitz-type serine protease inhibitor that is mainly known for its inhibition of tissue factor-mediated coagulation. In addition to its anticoagulant properties, emerging data show that TFPI may also regulate endothelial cell functions via a non-haemostatic pathway. In this work we demonstrate that at concentrations within the physiological range,TFPI inhibits both endothelial cell migration and their differentiation into capillary-like structures in vitro.These effects were specific to endothelial cells since no inhibitory effect was observed on the migration of tumor (glioblastoma) cells. Inhibition of endothelial cell migration was correlated with a concomitant loss in cell adhesion,suggesting an alteration of focal adhesion complex integrity. Accordingly,we observed thatTFPI inhibited the phosphorylation of focal adhesion kinase and paxillin,two key proteins involved in the scaffolding of these complexes, and that this effect was specific to endothelial cells. These results suggest that TFPI influences the angiogenic process via a non-haemostatic pathway, by downregulating the migratory mechanisms of endothelial cells.

You may also be interested in...

1.
Yona Nadir 1,2, Benjamin Brenner 2, Sveta Gingis-Velitski 1, Flonia Levy-Adam 1, Neta Ilan 1, Eyal Zcharia 3, Erez Nadir 4, Israel Vlodavsky1

Thromb Haemost 2008 99 1: 133-141

2.
Ping Ping Huang 1, Xiao Feng Yang 2, Shan Zhu Li 1, Jin Chao Wen 1, Yan Zhang 1, Zhong Chao Han1

Thromb Haemost 2007 98 6: 1335-1342

https://doi.org/10.1160/TH07-02-0137

3.

Süleyman Ergün 1, Derya Tilki 2, Hans-Peter Hohn 1, Ursula Gehling 3, Nerbil Kilic4

Thromb Haemost 2007 98 5: 930-939

https://doi.org/10.1160/TH07-04-0318